Englert W, Schlich D
Fortschr Med. 1978 Jun 1;96(21):1150-2.
In a double-blind cross-over study over eight weeks two groups of 24 patients each with symptoms of chronic postprandial dyspepsia received during the first four-week period either 10 mg domperidon t.i.d. or placebo. After four weeks the medication was exchanged. Despite some improvement of symptoms under placebo, statistical analysis revealed a significantly higher improvement rate after domperidon.
在一项为期八周的双盲交叉研究中,两组各24名有慢性餐后消化不良症状的患者,在头四周期间,一组接受每日三次、每次10毫克多潘立酮治疗,另一组接受安慰剂治疗。四周后药物交换。尽管安慰剂治疗后症状有所改善,但统计分析显示,多潘立酮治疗后的改善率显著更高。